But the industry is growing in western Canada and Alaska, and it's being studied as a possible add-on venture for maple syrup producers across the northeastern United States.
But they are not now applying for approval for this use, because the FDA is nervous about releasing an exotic new drug for such a large group of patients until it has been studiedon more people.